Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycerol and sodium pentaborate for prevention of postoperative peritoneal adhesion
IRCT20190618043923N5Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of glycerol and sodium pentaborate pentahydrate in Peritoneal adhesions (ARD) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Microscopic peritoneal adhesion and Gross peritoneal adhesion. Started May 2020; status: completed.
02
Drugs
glycerolsodium pentaborate pentahydrate
03
Conditions
Peritoneal adhesions (ARD)
Beyond the preview
Go deeper on IRCT20190618043923N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190618043923N5.